Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Dana-Farber Cancer Institute

Dana-Farber Cancer Institute to Study Paxalisib in Lymphoma-based Brain Cancer

Boston-based Dana-Farber Cancer Institute (DFCI) entered into a collaborative agreement with an Australian oncology-focused biotech called Kazia Therapeutics Limited (ASX: […]

Dana-Farber Cancer Institute to Study Paxalisib in Lymphoma-based Brain Cancer
5 months ago
Share

Florida’s Benderson Family Donate $5m to Dana-Farber to Help Research Triple-Negative Breast Cancer Cures

The Benderson family of Sarasota, Florida, donated $5 million to the Dana-Farber Cancer Institute in Boston, MA, representing the largest […]

Florida’s Benderson Family Donate $5m to Dana-Farber to Help Research Triple-Negative Breast Cancer Cures
6 months ago
Share

Novel Approaches for GVHD on the Horizon Reports Stem Cell Transplant Program Lead

Patients with acute or chronic graft-versus-host disease (GVHD) have several unmet needs, including later-line therapies. Novel agents and other research […]

Novel Approaches for GVHD on the Horizon Reports Stem Cell Transplant Program Lead
1 year ago
Share

William G. Kaelin, Jr. MD Dana-Farber Cancer Institute and 2019 Nobel Prize Winner & Live Saver

William G. Kaelin, Jr. MD won the 2019 Nobel Prize in medicine. His research findings at Dana-Farber are game-changing: a […]

William G. Kaelin, Jr. MD Dana-Farber Cancer Institute and 2019 Nobel Prize Winner & Live Saver
1 year ago
Share

Dana-Farber Clinical Investigators Leverage Rich Patient Samples to Pursue Novel Cancer Therapies

Young Dana-Farber investigators Jennifer Guerriero, PhD and Sarah Hill, MD, PhD are on a mission to find better treatments for […]

Dana-Farber Clinical Investigators Leverage Rich Patient Samples to Pursue Novel Cancer Therapies
1 year ago
Share

Dana-Farber & Other Sites Spur New Wave of Clinical Trials of Therapies for T-Cell Lymphoma

A surge of clinical trials with great potential for promising new treatments for T-cell lymphoma are based on significant basic […]

Dana-Farber & Other Sites Spur New Wave of Clinical Trials of Therapies for T-Cell Lymphoma
1 year ago
Share

Dana-Farber Cancer Institute Receives $5M for Myelodysplastic Syndromes Research

The Dana-Farber Cancer Institute has received a $5 million gift from the Edward P. Evans Foundation in support of research […]

1 year ago
Share

Dana-Farber Cancer Institute Leads Clinical Trial of First-in-Class Imaging Agent

ImaginAB Inc., a Los Angeles-based, immune-oncology imaging company focused on offering actionable insight into patient selection and treatment for cancer […]

Dana-Farber Cancer Institute Leads Clinical Trial of First-in-Class Imaging Agent
2 years ago
Share

Harvard Health Explains Whether a Cancer Trial is the Right Choice for a Patient

Dana-Farber Cancer Institute’s Guru P Sonpavde explains what clinical trials are and who they may be appropriate for.  Dr. Sonpavde, […]

2 years ago
Share

Dana-Farber Cancer Institute Identifies New Drug Targets in Aggressive Cancers

Science Daily reports that Dana-Farber Cancer Institute researchers have discovered a previously unknown molecular vulnerability in two rare, aggressive and […]

2 years ago
Share

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.